CORV
Correvio Pharma Corp.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada.
Market Cap: 27.8 Million
Primary Exchange: NASDAQ
Website: http://www.correvio.com
Shares Outstanding: 66.2 Million
Float: 61.3 Million
Dividend: (%)
Beta: -0.03597582832224281
Sector: Health Technology
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1387 trading days
From: 2018-08-17 To: 2020-05-27
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|